Product NDC: | 0555-0285 |
Proprietary Name: | Dipyridamole |
Non Proprietary Name: | Dipyridamole |
Active Ingredient(s): | 50 mg/1 & nbsp; Dipyridamole |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0555-0285 |
Labeler Name: | Barr Laboratories Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA087716 |
Marketing Category: | ANDA |
Start Marketing Date: | 19820101 |
Package NDC: | 0555-0285-05 |
Package Description: | 1000 TABLET, FILM COATED in 1 BOTTLE (0555-0285-05) |
NDC Code | 0555-0285-05 |
Proprietary Name | Dipyridamole |
Package Description | 1000 TABLET, FILM COATED in 1 BOTTLE (0555-0285-05) |
Product NDC | 0555-0285 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Dipyridamole |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19820101 |
Marketing Category Name | ANDA |
Labeler Name | Barr Laboratories Inc. |
Substance Name | DIPYRIDAMOLE |
Strength Number | 50 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |